Prevent Cancer Foundation welcomes largest-ever Corporate Membership Program cohort in 2026
PARA PUBLICACIÓN INMEDIATA
Kyra Meister
703-836-1746
kyra.meister@preventcancer.org
Alexandria, Va. – The Prevent Cancer Foundation® is proud to welcome 23 leading companies to its Corporate Membership Program. Together, they make up the program’s largest-ever cohort, strengthening a growing network of business leaders dedicated to reducing the impact of cancer through prevention and early detection.
Program members receive exclusive access to Foundation events and resources while providing vital support for the Foundation’s work in education, outreach, advocacy and community. Through collaboration and the exchange of ideas, members help advance cancer prevention and early detection efforts, empowering people to take steps that can improve health outcomes and save more lives.
“Our corporate partners play a vital role in advancing cancer prevention and early detection nationwide,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “We’re proud to work alongside companies that share our vision of a world where cancer is preventable, detectable and beatable for all.”
The 2026 class of corporate members, as of the date of this publication, include:
Silver members
- Abbott
- Bristol-Myers Squibb
- holológico
- Pfizer
- PhRMA
Bronze members
- AbbVie
- Astellas
- AstraZeneca
- Boehringer Ingelheim
- Eisai
- Eli Lilly & Co
- Exelixis
- nombre libre
- genetech
- Geneoscopy
- GSK
- Salud guardián
- merck
- Mercy BioAnalytics
- Natera
- Novartis
- sanofi
The Corporate Membership Program is open to companies who support the Foundation’s mission: Stopping Cancer. Saving Lives. To learn more or inquire about joining, contact Anne Potter, Senior Director of Corporate and Foundation Relations, at anne.potter@prevencancer.org.
###
Acerca de la Fundación Prevent Cancer®
La Fundación para Prevenir el Cáncer® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Through research, education, advocacy and community, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated. We are driven by a vision of a world where cancer is preventable, detectable and beatable for all.
La Fundación está avanzando para afrontar el desafío de reducir las muertes por cáncer en 40% para 2035. Para lograrlo, nos comprometemos a invertir $20 millones en tecnologías innovadoras para detectar el cáncer tempranamente y avanzar en la detección de múltiples cánceres, $10 millones para ampliar la detección del cáncer y la vacunación. acceso a comunidades médicamente desatendidas, y $10 millones para educar al público sobre las opciones de detección y vacunación.
Para mayor información por favor visite www.preventcancer.org.